FDA - Search News

FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

FDA approves first new type of pain medication in 25 years

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill that’s taken every 12 hours after a larger starter dose.

The Associated Press on MSN · 5h

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

Hosted on MSN · 4h

What Is Journavx? First Pain Medication Approved by FDA in Over Two Decades

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

FDA, migraine and Symbravo

Reuters · 9h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Business Insider · 8h

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Investing.com on MSN · 7h

FDA approves new migraine treatment SYMBRAVO

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,

type 2 diabetes, chronic kidney disease and FDA

CNN on MSN · 2d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

Reuters · 2d

US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),

U.S. News & World Report · 1d

FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes

Doctors already use Ozempic to manage type 2 diabetes and reduce the risk of heart disease in patients with diabetes. This move, as reported by The Times, was based on research sh

Recall raised to highest risk level by FDA. What to know

Newsweek on MSN · 1d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

Fortune on MSN · 1d

FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’

The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.

The Record, Bergen County on … · 15h

Frito Lay's Classic Potato Chips: Recall raised to highest risk level by FDA. What to know

The Food and Drug Administration just raised the recall level of Lay’s Classic Potato Chips to the highest risk classification. Frito Lay issued a recall on Dec. 16 through the FDA for over 6,000 bags of Lay's Classic Potato Chips that contained "undeclared milk.

1don MSN

Broccoli Recall Update as FDA Sets Highest Risk Level Over Bacteria Fears

Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been ...

2don MSN

Trump admin's FDA withdraws proposed federal rule to ban menthol cigarettes

Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering ...

What really helps in the quest to maintain mental fitness?

All the experts say socializing, ideally while doing that intellectual activity, can help a lot, because it not only stimulates the brain, but keeps us from feeling lonely. Loneliness often leads to ...

1hon MSN

Intel's reliance on US funding is a symptom of its problems, says analyst

Ed Snyder of Charter Equity Research reacts to Intel's latest set of earnings, saying government help will not be enough to help turn the company's fortunes around.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

FDA, migraine and Symbravo

type 2 diabetes, chronic kidney disease and FDA

Recall raised to highest risk level by FDA. What to know

Related topics